Advertisement

Topics

GTx Provides Corporate Update and Reports Third Quarter 2017 Financial Results

16:05 EST 14 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
-- Positive results achieved in all patients after 12-week treatment in the enobosarm Phase 2 proof-of-concept clinical trial in women with stress urinary incontinence (SUI) -- -- Enobosarm Phase 2 proof-of-concept clin...

Other Sources for this Article

Investors:
Argot Partners
Kimberly Minarovich or Sam Martin, 212-600-1902
or
Media:
Red House Consulting
Denise Powell, 510-703-9491
denise@redhousecomms.com

NEXT ARTICLE

More From BioPortfolio on "GTx Provides Corporate Update and Reports Third Quarter 2017 Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Mental Health
Adhd Anorexia Depression Dyslexia Mental Health Psychiatry Schizophrenia Stress Mental health, although not being as obvious as physical health, is very important, causing great unhappiness to those affected, causing add...